CLARAVA Trademark

Trademark Overview


On Friday, March 5, 2021, a trademark application was filed for CLARAVA with the United States Patent and Trademark Office. The USPTO has given the CLARAVA trademark a serial number of 90563233. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, June 12, 2024. This trademark is owned by Verici Dx Plc. The CLARAVA trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes

Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence

Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients

Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence
clarava

General Information


Serial Number90563233
Word MarkCLARAVA
Filing DateFriday, March 5, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, June 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements


Goods and ServicesMedical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and chemical reagents for medical purposes
Goods and ServicesMedical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence
Goods and ServicesBlood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients
Goods and ServicesDevelopment of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis; none of the foregoing in the fields of business analytics, market intelligence, or business intelligence

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, June 5, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVerici Dx Plc
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCardiff CF642EZ
GB

Party NameVerici Dx Plc
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCardiff CF642EZ
GB

Trademark Events


Event DateEvent Description
Tuesday, March 9, 2021NEW APPLICATION ENTERED
Saturday, June 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 27, 2021ASSIGNED TO EXAMINER
Monday, September 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, November 17, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 17, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 17, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, November 17, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, May 3, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, May 12, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Wednesday, May 18, 2022ASSIGNED TO PETITION STAFF
Wednesday, May 18, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, June 28, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 21, 2022SOU EXTENSION 1 FILED
Wednesday, December 21, 2022SOU EXTENSION 1 GRANTED
Friday, December 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, June 7, 2023SOU EXTENSION 2 FILED
Wednesday, June 7, 2023SOU EXTENSION 2 GRANTED
Friday, June 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 13, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 13, 2023SOU EXTENSION 3 FILED
Wednesday, December 13, 2023SOU EXTENSION 3 GRANTED
Friday, December 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, June 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 13, 2024SOU EXTENSION 4 GRANTED
Thursday, June 13, 2024SOU EXTENSION 4 FILED